rs72552387

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2

The NM_138715.3(MSR1):​c.520G>T​(p.Asp174Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00121 in 1,614,122 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.0062 ( 10 hom., cov: 33)
Exomes 𝑓: 0.00069 ( 16 hom. )

Consequence

MSR1
NM_138715.3 missense

Scores

9
9

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 1.11

Publications

21 publications found
Variant links:
Genes affected
MSR1 (HGNC:7376): (macrophage scavenger receptor 1) This gene encodes the class A macrophage scavenger receptors, which include three different types (1, 2, 3) generated by alternative splicing of this gene. These receptors or isoforms are macrophage-specific trimeric integral membrane glycoproteins and have been implicated in many macrophage-associated physiological and pathological processes including atherosclerosis, Alzheimer's disease, and host defense. The isoforms type 1 and type 2 are functional receptors and are able to mediate the endocytosis of modified low density lipoproteins (LDLs). The isoform type 3 does not internalize modified LDL (acetyl-LDL) despite having the domain shown to mediate this function in the types 1 and 2 isoforms. It has an altered intracellular processing and is trapped within the endoplasmic reticulum, making it unable to perform endocytosis. The isoform type 3 can inhibit the function of isoforms type 1 and type 2 when co-expressed, indicating a dominant negative effect and suggesting a mechanism for regulation of scavenger receptor activity in macrophages. [provided by RefSeq, Jul 2008]
MSR1 Gene-Disease associations (from GenCC):
  • Barrett esophagus
    Inheritance: Unknown Classification: LIMITED Submitted by: Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07389018).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00623 (949/152300) while in subpopulation AFR AF = 0.0216 (896/41566). AF 95% confidence interval is 0.0204. There are 10 homozygotes in GnomAd4. There are 467 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 10 Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MSR1NM_138715.3 linkc.520G>T p.Asp174Tyr missense_variant Exon 4 of 10 ENST00000262101.10 NP_619729.1 P21757-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MSR1ENST00000262101.10 linkc.520G>T p.Asp174Tyr missense_variant Exon 4 of 10 1 NM_138715.3 ENSP00000262101.5 P21757-1

Frequencies

GnomAD3 genomes
AF:
0.00623
AC:
948
AN:
152182
Hom.:
10
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0216
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00229
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00165
AC:
414
AN:
251352
AF XY:
0.00132
show subpopulations
Gnomad AFR exome
AF:
0.0220
Gnomad AMR exome
AF:
0.00101
Gnomad ASJ exome
AF:
0.0000993
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000132
Gnomad OTH exome
AF:
0.000653
GnomAD4 exome
AF:
0.000692
AC:
1011
AN:
1461822
Hom.:
16
Cov.:
32
AF XY:
0.000638
AC XY:
464
AN XY:
727202
show subpopulations
African (AFR)
AF:
0.0225
AC:
754
AN:
33480
American (AMR)
AF:
0.000917
AC:
41
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39686
South Asian (SAS)
AF:
0.0000580
AC:
5
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.00295
AC:
17
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000683
AC:
76
AN:
1111968
Other (OTH)
AF:
0.00195
AC:
118
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
54
108
162
216
270
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00623
AC:
949
AN:
152300
Hom.:
10
Cov.:
33
AF XY:
0.00627
AC XY:
467
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.0216
AC:
896
AN:
41566
American (AMR)
AF:
0.00229
AC:
35
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68032
Other (OTH)
AF:
0.00473
AC:
10
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
48
96
143
191
239
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00229
Hom.:
6
Bravo
AF:
0.00673
ESP6500AA
AF:
0.0175
AC:
77
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00197
AC:
239
Asia WGS
AF:
0.00462
AC:
16
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.000237

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Prostate cancer Uncertain:2
May 28, 2019
Mendelics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 01, 2002
OMIM
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:literature only

- -

not provided Uncertain:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.29
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Uncertain
-0.050
CADD
Benign
19
DANN
Uncertain
0.98
DEOGEN2
Benign
0.35
.;T;.;.;.
Eigen
Benign
-0.070
Eigen_PC
Benign
-0.27
FATHMM_MKL
Benign
0.13
N
LIST_S2
Uncertain
0.89
D;D;D;.;D
MetaRNN
Benign
0.074
T;T;T;T;T
MetaSVM
Uncertain
0.0096
D
MutationAssessor
Uncertain
2.3
M;M;.;M;M
PhyloP100
1.1
PrimateAI
Benign
0.30
T
PROVEAN
Uncertain
-3.1
D;D;D;D;D
REVEL
Uncertain
0.51
Sift
Uncertain
0.0090
D;D;D;D;D
Sift4G
Uncertain
0.0090
D;D;D;D;D
Polyphen
1.0
D;D;D;D;D
Vest4
0.68
MVP
0.87
MPC
0.010
ClinPred
0.028
T
GERP RS
3.4
Varity_R
0.16
gMVP
0.32
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72552387; hg19: chr8-16026077; COSMIC: COSV50508400; COSMIC: COSV50508400; API